SCHEMBL3035678

SCHEMBL3035678

NC(=O)c1cccc(-c2ccc(C(=O)NO)cc2)c1Cc1ccc(F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 15/20 0.45
▸ HDAC1 Q13547 10/20 0.44
▸ HDAC8 Q9BY41 10/20 0.44
▸ HDAC3 O15379 8/20 0.44
▸ NCOR2 Q9Y618 8/20 0.44
▸ HDAC2 Q92769 8/20 0.44
▸ HDAC11 Q96DB2 8/20 0.44
▸ HDAC4 P56524 7/20 0.44
▸ HDAC7 Q8WUI4 7/20 0.44
▸ HDAC10 Q969S8 7/20 0.44
▸ HDAC9 Q9UKV0 7/20 0.44
▸ HDAC5 Q9UQL6 7/20 0.44
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ AGTR1 P30556 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ RPS6KB1 P23443 1/20 0.40
▸ PTGER2 P43116 1/20 0.40
▸ ABL1 P00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3037600 0.90 HDAC1 (0.47) HDAC6HDAC1HDAC8HDAC3NCOR2
SCHEMBL3032639 0.89 HDAC6 (0.44) HDAC6HDAC1HDAC8HDAC3NCOR2
SCHEMBL3029944 0.89 HDAC6 (0.44) HDAC6HDAC1HDAC8HDAC3NCOR2
SCHEMBL3026062 0.82 HDAC1 (0.52) HDAC6HDAC1HDAC8HDAC3NCOR2
SCHEMBL3024501 0.82 HDAC6 (0.41) HDAC6HDAC1HDAC8HDAC3NCOR2
SCHEMBL3034724 0.82 HDAC6 (0.48) HDAC6HDAC1HDAC8ALDH1A1MAPT
SCHEMBL3029955 0.81 HDAC6 (0.43) HDAC6HDAC1HDAC8HDAC11ALDH1A1
SCHEMBL3034462 0.78 HDAC1 (0.47) HDAC6HDAC1HDAC8HDAC3NCOR2
SCHEMBL27895663 0.78 RPS6KB1 (0.46) ALDH1A1AGTR1AURKARPS6KB1
SCHEMBL3017472 0.74 HDAC1 (0.53) HDAC6HDAC1HDAC8HDAC3NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 — — US claimed
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 HDAC6 31/4885HDAC1 5/4885HDAC8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback